Focused on building companies through early-stage, opportunistic, and diversified investments in cannabis space Spun off from Aurora in late 2018 Aims to establish a foothold in the US before US federal legalization shifts What Australis Capital does:
Australis was spun out from cannabis behemoth Aurora Cannabis Inc (TSE:ACB) (NYSE:ACB) in September 2018 as its US investment vehicle. Despite boasting a C$9.2 billion market cap, Aurora is not allowed to invest in US cannabis assets due to Toronto Stock Exchange and NYSE listing rules. Australis is therefore Aurora’s arm to establish a foothold in the US, before a potential US federal legalization shift.
Whereas Aurora is headquartered in Canada and has global assets, Australis’s US headquarters reflect its strategic focus on the burgeoning American marijuana industry.
The Nevada-headquartered firm has ten assets in the cannabis industry, four of which are wholly owned. This includes brands, such as Body & Mind, Mr Natural and Green Therapeutics. In addition to this, the company has invested in cannabis tracking and loyalty app developer rthm and Wagner Dimas, which holds a number of patents for industrial-scaled pre-roll machines.
The firm has stringent investment criteria, with a focus on near and mid-term high-quality opportunities with strong return potential. It looks for companies that have intellectual property and strong, recognizable brands with a focus on control positions, as opposed to passive investments.
Australis acquired certain brands and cultivation assets of Nevada’s Green Therapeutics, including Tsunami, Provisions, and GT Flowers, as well as the right to assume and expand the construction of a 55,000 sq/ft cultivation and production facility in North Las Vegas, Nevada.
Australis also has a recently boosted 36% stake in